P-Anisidine → HCID 22557950, 화합물

HRID 395450노트

반응식

HRID 395450 반응식
[CH3:1][O:2][C:3]1[CH:4]=[C:5]([C:15]2[CH:20]=[C:19]([CH2:21][N:22]3[CH2:27][CH2:26][C:25](=O)[CH2:24][CH2:23]3)[CH:18]=[CH:17][N:16]=2)[CH:6]=[C:7]([O:13][CH3:14])[C:8]=1[O:9][CH:10]([CH3:12])[CH3:11].[CH3:29][O:30][C:31]1[CH:36]=[CH:35][C:34]([NH2:37])=[CH:33][CH:32]=1>>[CH3:29][O:30][C:31]1[CH:36]=[CH:35][C:34]([NH:37][CH:25]2[CH2:26][CH2:27][N:22]([CH2:21][C:19]3[CH:18]=[CH:17][N:16]=[C:15]([C:5]4[CH:6]=[C:7]([O:13][CH3:14])[C:8]([O:9][CH:10]([CH3:11])[CH3:12])=[C:3]([O:2][CH3:1])[CH:4]=4)[CH:20]=3)[CH2:23][CH2:24]2)=[CH:33][CH:32]=1

참가 물질

3

반응물 2

HCID 7732P-AnisidineHCID 22557797HCID 22557797, 화합물

생성물 1

HCID 22557950HCID 22557950, 화합물

실험 절차

1-[[2-(3,5-dimethoxy-4-isopropoxyphenyl)pyridin-4-yl]methyl]-4-piperidone (350 mg) and p-anisidine (123 mg) were condensed in the same manner as described in Preparation Example 37 to give the title compound.

후처리

  1. customcondensed in the same manner
  2. customas described in Preparation Example 37

출처 및 근거

ORD 기록
ord-00162ee3e24c4eda9908f0332a8fb4a4
출처 데이터셋
uspto-grants-2003_08
특허 번호
US06605620B1

반응 노트

불러오는 중…